drugset / Trial / NCT01011998
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to test the effect of the combination of valproate in combination with imatinib with an aim of achieving a maximal molecular response as the primary goal.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valproic Acid | Small molecule | 250 mg | — |
| Background | Imatinib | Small molecule | — | — |